Sequoia China-backed health tech unicorn Medlinker has set up a 500-million-yuan ($75.9 million) industry investment fund, while Gene+ Technology has closed over 250 million yuan ($38 million) in a Series B+ round of financing led by Huagai Capital.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
